Xponance’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.58M | Sell |
25,521
-3,540
| -12% | -$913K | 0.06% | 267 |
|
|
2025
Q1 | $6.51M | Buy |
29,061
+353
| +1% | +$79K | 0.06% | 245 |
|
|
2024
Q4 | $6.57M | Sell |
28,708
-2,564
| -8% | -$586K | 0.06% | 247 |
|
|
2024
Q3 | $7.63M | Sell |
31,272
-3,182
| -9% | -$777K | 0.07% | 216 |
|
|
2024
Q2 | $6.6M | Sell |
34,454
-12,552
| -27% | -$2.4M | 0.07% | 226 |
|
|
2024
Q1 | $9.31M | Buy |
47,006
+268
| +0.6% | +$53.1K | 0.1% | 177 |
|
|
2023
Q4 | $8.04M | Buy |
46,738
+3,363
| +8% | +$579K | 0.1% | 177 |
|
|
2023
Q3 | $6.41M | Buy |
43,375
+6,359
| +17% | +$940K | 0.09% | 193 |
|
|
2023
Q2 | $8.09M | Buy |
37,016
+4,478
| +14% | +$978K | 0.11% | 164 |
|
|
2023
Q1 | $7.13M | Buy |
32,538
+671
| +2% | +$147K | 0.1% | 180 |
|
|
2022
Q4 | $6.63M | Buy |
31,867
+3,121
| +11% | +$650K | 0.11% | 182 |
|
|
2022
Q3 | $6.28M | Buy |
28,746
+2,217
| +8% | +$484K | 0.12% | 151 |
|
|
2022
Q2 | $5.56M | Buy |
26,529
+3,638
| +16% | +$763K | 0.11% | 159 |
|
|
2022
Q1 | $5.55M | Buy |
22,891
+316
| +1% | +$76.6K | 0.09% | 181 |
|
|
2021
Q4 | $5.88M | Buy |
22,575
+1,990
| +10% | +$518K | 0.09% | 188 |
|
|
2021
Q3 | $5.43M | Sell |
20,585
-659
| -3% | -$174K | 0.1% | 173 |
|
|
2021
Q2 | $5.24M | Buy |
21,244
+91
| +0.4% | +$22.4K | 0.1% | 168 |
|
|
2021
Q1 | $4.1M | Buy |
21,153
+47
| +0.2% | +$9.12K | 0.09% | 194 |
|
|
2020
Q4 | $4.49M | Buy |
21,106
+356
| +2% | +$75.7K | 0.1% | 174 |
|
|
2020
Q3 | $3.56M | Buy |
20,750
+18
| +0.1% | +$3.09K | 0.09% | 189 |
|
|
2020
Q2 | $3.98M | Buy |
+20,732
| New | +$3.98M | 0.1% | 174 |
|